PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1573-7217

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer ; volume:138 ; number:2 ; day:20 ; month:2 ; year:2013 ; pages:457-466 ; date:4.2013
Breast cancer research and treatment ; 138, Heft 2 (20.2.2013), 457-466, 4.2013

Creator: Martín, Miguel
Prat, Aleix
Rodríguez-Lescure, Álvaro
Caballero, Rosalía
Ebbert, Mark T. W.
Munárriz, Blanca
Ruiz-Borrego, Manuel
Bastien, Roy R. L.
Crespo, Carmen
Davis, Carole
Rodríguez, César A.
López-Vega, José M.
Furió, Vicente
García, Ana M.
Casas, Maribel
Ellis, Matthew J.
Berry, Donald A.
Pitcher, Brandelyn N.
Harris, Lyndsay
Ruiz, Amparo
Winer, Eric
Hudis, Clifford
Stijleman, Inge J.
Tuck, David P.
Carrasco, Eva
Perou, Charles M.
Bernard, Philip S.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s10549-013-2416-2

URN: urn:nbn:de:101:1-2019080201531137740905

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Martín, Miguel
Prat, Aleix
Rodríguez-Lescure, Álvaro
Caballero, Rosalía
Ebbert, Mark T. W.
Munárriz, Blanca
Ruiz-Borrego, Manuel
Bastien, Roy R. L.
Crespo, Carmen
Davis, Carole
Rodríguez, César A.
López-Vega, José M.
Furió, Vicente
García, Ana M.
Casas, Maribel
Ellis, Matthew J.
Berry, Donald A.
Pitcher, Brandelyn N.
Harris, Lyndsay
Ruiz, Amparo
Winer, Eric
Hudis, Clifford
Stijleman, Inge J.
Tuck, David P.
Carrasco, Eva
Perou, Charles M.
Bernard, Philip S.
SpringerLink (Online service)

Other Objects (12)

Severe skin toxicity due to weekly paclitaxel administration

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer

Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort

Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome

Hochschulschrift

Preoperative MELD score as a predictor for post hemihepatectomy complications

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients

Severe skin toxicity due to weekly paclitaxel administration

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer

Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort

Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome

Hochschulschrift

Preoperative MELD score as a predictor for post hemihepatectomy complications

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients

Severe skin toxicity due to weekly paclitaxel administration

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer

Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort

Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome

Hochschulschrift

Preoperative MELD score as a predictor for post hemihepatectomy complications

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Severe skin toxicity due to weekly paclitaxel administration

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer

Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort

Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome

Preoperative MELD score as a predictor for post hemihepatectomy complications

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients

Severe skin toxicity due to weekly paclitaxel administration

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer

Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort

Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome

Preoperative MELD score as a predictor for post hemihepatectomy complications

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients

Severe skin toxicity due to weekly paclitaxel administration

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer

Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort

Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study

Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome

Preoperative MELD score as a predictor for post hemihepatectomy complications

Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix

Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients

Related objects

Reset password